Hims Hers Health is trading 10.21% up now at $30.93, with supplied alert context linking the move to Oscar Health CEO Mark Bertolini’s discussion of talks to offer Hims retail drugs through Lucie Health Marketplace.
- The potential placement could add a distribution channel, including for cash-pay weight-loss treatments.
- A published account dates the talks report to August 16, not October 9; it does not independently confirm a connection to Friday’s sharp gain.